Clinical Trials Logo

Medication Adherence clinical trials

View clinical trials related to Medication Adherence.

Filter by:

NCT ID: NCT03863353 Completed - Pain, Postoperative Clinical Trials

Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults

STOMPYA
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Legitimate prescription opioid use during adolescence has been associated with later prescription opioid misuse and substance use disorder symptoms during adulthood. Thus, primary prevention interventions for older adolescents and young adults (15-24 yrs) at the time of prescribing are imperative. The goal of our research is to improve opioid analgesic safety and efficacy by optimizing opioid risk recognition and informed decision-making among 15-24 year olds who are prescribed these agents for home use. Young adults and older adolescents who manage their own prescription pain medicines need to recognize opioid-related risks and make decisions that will both reduce these risks yet ensure effective pain relief. The proposed research will evaluate new strategies to help subjects learn about opioid risks and make safe and effective analgesic decisions. 355 subjects who are undergoing an elective surgical procedure will be recruited. Subjects will be randomized to receive the new educational routine information. Subjects' knowledge and perceptions will be evaluated at baseline and at critical times after surgery.

NCT ID: NCT03861845 Completed - Chronic Disease Clinical Trials

Impact of Pillboxes on Medical Adherence

Start date: February 10, 2019
Phase: N/A
Study type: Interventional

This study uses an experimental design to test the impact of different types of pillboxes on medication adherence. Participants in this study will randomized to receive one of the three pillbox interventions: 1) A standard seven day a week, one-dose per day pillbox with training 2) an off-the-shelf pillbox that was purchased specifically for the individual's needs with training and education, or 3) a customized 3D printed pillbox that was designed and manufactured specifically to the individual's needs with training and education. Participants will have three visits with the research team to collect baseline data, receive the pillbox, and collect follow up data. Risks to the study include loss of time, boredom, invasion of privacy, and medication errors. The investigators have taken precautions to mitigate these risks. This study will improve understanding of medication adherence and potentially help us better address poor medication adherence which needlessly causes morbidity, mortality, and costs over $300 million in unnecessary healthcare costs each year.

NCT ID: NCT03853213 Completed - Clinical trials for Acute Coronary Syndrome

Investigating Fear Of Recurrence as a Modifiable Mechanism of Behavior Change

INFORM
Start date: March 28, 2019
Phase: N/A
Study type: Interventional

The primary goal of this project is to identify, measure, and influence fear of cardiac event recurrence, a candidate mechanism of change in medication adherence in patients with suspected acute coronary syndrome (ACS). An intervention will be tested that has been used to reduce fear of cancer recurrence by changing emotion-related patterns of attention allocation and interpretation of neutral stimuli. Secondarily, the study will test whether a reduction in fear of cardiac event recurrence improves medication adherence.

NCT ID: NCT03805451 Completed - HIV Clinical Trials

Life Steps for PrEP for Youth

LSPY
Start date: September 27, 2019
Phase: N/A
Study type: Interventional

This is a formative study, designed to provide information required to tailor Life-Steps for Pre-Exposure Prophylaxis (PrEP), an evidence-based cognitive behavioral adherence intervention, to enhance PrEP uptake and adherence in high risk young men who have sex with men (YMSM) and young transgender women who have sex with men (YTWSM). Life-Steps for Pre-exposure prophylaxis (PrEP) is a manualized modular adherence intervention based on principles of cognitive-behavioral therapy (CBT), that allows for recipients of the intervention to focus on the greatest challenges that they perceive in maintaining optimal adherence to PrEP.

NCT ID: NCT03804905 Not yet recruiting - Clinical trials for Type 2 Diabetes Mellitus

STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Importantly, many of these uninsured patients already face other barriers to good health: low income, new immigrants, single mothers, etc. For these patients, taking prescription drugs - especially chronic disease treatments that may be required lifelong - can be difficult due to high costs. Patients skip doses, delay renewing prescriptions, or simply do not fill prescriptions recommended by their doctors, because they do not have insurance to cover the costs of prescriptions. Previous research by the study team has suggested that the lack of a universal drug insurance program for working-age Canadians affects the health and well-being of low-income people with diabetes. The goal of this research is to determine the clinical and economic impact of providing drug coverage for uninsured type 2 diabetics.

NCT ID: NCT03794713 Not yet recruiting - Clinical trials for Medication Adherence

A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The present study aims to enhance the adherence of beta-blockers by Patient Support Tool through a smart phone application and a wristband, subsequently reduce the risk of angina attacks in patients with stable angina pectoris.

NCT ID: NCT03781830 Withdrawn - Clinical trials for Liver Transplantation

mDOT for Immunosuppressant Adherence in Adolescent Liver Transplant Recipients

Start date: June 18, 2020
Phase: N/A
Study type: Interventional

The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of immunosuppression medication adherence among adolescent liver transplant recipients. The investigators aim to test this by recruiting adolescent (ages 14-21) liver transplant recipients to use an mHealth application to record themselves taking their immunosuppression medications, and tracking medication adherence over time. The study population will be approximately 25 adolescent liver transplant recipients at the Johns Hopkins Hospital.

NCT ID: NCT03775044 Active, not recruiting - Clinical trials for Medication Adherence

Assessment of Medherent Medication Management Device and Adherence Platform

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This study uses a stepped wedge designs to estimate the effect of using the Medherent Medication Management Device on medication adherence for a population of 150 individuals who are diagnosed with serious mental illness.

NCT ID: NCT03769519 Completed - Asthma Clinical Trials

AdheRence to Inhaled Corticosteroids in Asthma

ARICA
Start date: February 27, 2020
Phase: N/A
Study type: Interventional

It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.

NCT ID: NCT03766503 Completed - Clinical trials for Medication Adherence

Daily Delivery and Supervision of Psychotropic Medication for High-Risk Patients With Severe/Persistent Mental Illness

Start date: October 15, 2016
Phase: N/A
Study type: Interventional

The main study intervention is the daily witnessing of participant self-administration of medications by trained pharmacy staff to ensure compliance. The staff in question will be provided by Leila pharmacy and will in addition provide support so that individuals can transition back into living independently through reminders to attend regularly scheduled medical appointments and counseling on correct use of prescribed medications.